Q-omics provides the consensus-scored MIR548G profile across patient tissues and cancer cell-line models. MIR548G expression is associated with patient survival in 4 of 34 cancer types, with the highest sampling consensus in CESC. Additionally, MIR548G RNA expression shows 6,957 significant gene co-expression associations, with the highest sampling consensus in LUSC. Together, these results highlight CESC, and LUSC as cancer lineages where MIR548G shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.